DexCom Aktie

DexCom für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN: A0D9T1 / ISIN: US2521311074

<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
05.01.2015 14:46:54

DexCom Appoints Kevin Sayer As CEO - Quick Facts

(RTTNews) - DexCom, Inc. (DXCM) announced the appointment of Kevin Sayer, currently the Company's President and Chief Operating Officer, as President and Chief Executive Officer.

The company said Sayer will succeed Terry Gregg, who is transitioning to the role of Executive Chairman after more than seven years of service as DexCom's President and Chief Executive Officer.

Commenting on Sayer, the company stated that he has served as DexCom's President and Chief Operating Officer since January 2013, as President since June 2011, and as a board member since November 2007.

From April 2007 to December 2010, Sayer served as Chief Financial Officer of Biosensors International Group, Ltd., a medical technology company developing, manufacturing and commercializing medical devices used in interventional cardiology and critical care procedures. Previously, Sayer served as Chief Financial Officer of MiniMed, Inc. from 1994 until its acquisition by Medtronic, Inc. in 2001, DexCom noted.

Analysen zu DexCom Inc.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

DexCom Inc. 76,03 0,93% DexCom Inc.